Tuberc Respir Dis.  2013 Dec;75(6):236-237.

Overview of ALK and ROS1 Rearranged Lung Cancer

Affiliations
  • 1Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ccm@amc.seoul.kr

Abstract

Many attempts have been made to find genetic abnormalities inducing carcinogenesis after the development of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor targeting EGFR in lung cancer. New target therapies have been already commercialized and studied along with the recent discovery of gene rearrangement involved in the carcinogenic process of non-small cell lung cancer. This study aims to investigate anplastic lymphoma kinase, c-ros oncogene 1, and receptor tyrosine kinase, in particular.

Keyword

Lung Neoplasms; Anplastic Lymphoma Kinase; ROS1 Protein, Human

MeSH Terms

Carcinogenesis
Carcinoma, Non-Small-Cell Lung
Gene Rearrangement
Lung Neoplasms*
Lung*
Lymphoma
Oncogenes
Phosphotransferases
Protein-Tyrosine Kinases
Receptor, Epidermal Growth Factor
Phosphotransferases
Protein-Tyrosine Kinases
Receptor, Epidermal Growth Factor
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr